馬ヘルスケア市場- 成長、将来展望、競合分析、2023年～2031年

馬ヘルスケア市場は、予防ヘルスケア対策、診断と治療の進歩、馬術スポーツとレクリエーションへの注目の高まりといった主要促進要因によって、2024年から2032年の予測期間中にCAGR 6.1％で成長すると予測されています。しかし、コストやアクセスに関する課題が制約となっています。市場セグメンテーションでは、特定の製品カテゴリーと適応症の優位性が強調され、地理的動向では市場ダイナミクスの地域差が強調されています。競合情勢は、このダイナミックな市場を乗り切り、新たな機会を活用するための主要企業の戦略的努力を強調しています。馬ヘルスケア市場で持続的な成功を収めるには、業界が進化するにつれて、アクセシビリティの問題に対処し、イノベーションを促進することが極めて重要になります。

予防ヘルスケア重視の高まり

馬ヘルスケア市場は、馬の予防ヘルスケア重視の高まりにより、顕著な盛り上がりを見せています。馬主や世話人は、馬の病気を予防し、全体的な健康を維持するために、ワクチンや薬用飼料添加物の重要性を認識するようになってきています。この動向は、馬社会における予防ヘルスケアの採用が大幅に増加していることからも明らかです。

診断と治療の進歩

馬の診断と医薬品における進歩は、市場の成長に大きく貢献しています。筋骨格系障害、内科、馬ヘルペスウイルスや馬インフルエンザのようなウイルス感染に対する高度な診断ツールや効果的な医薬品の開発により、馬の様々な健康状態の診断と治療能力が向上しています。この動向は、馬の獣医診療における高度な診断と医薬品の使用の増加によって立証されています。

馬のスポーツとレクリエーションへの注目の高まり

馬のスポーツやレクリエーション活動の人気が高まっているため、パフォーマンスホース特有のニーズに合わせたヘルスケア製品やサービスの需要が高まっています。これには、筋骨格系障害や寄生虫駆除のための専門的治療、包括的ヘルスケア管理のためのソフトウェアやサービスの採用などが含まれます。さまざまな市場競争やレジャー活動への馬の参加が増加していることも、市場力学に影響を与える主要な要因です。

市場抑制要因

前向きな動向にもかかわらず、馬ヘルスケア市場はコストとアクセシビリティに関する顕著な抑制要因に直面しています。特に馬ヘルスケアリソースへのアクセスが限られている地域では、高度な診断、医薬品、専門的なヘルスケアサービスのコストが高く、馬主にとって課題となります。この制約が、馬社会の特定セグメントにおける先進ヘルスケアソリューションの普及を妨げています。

製品別市場分析：医薬品が市場を独占

馬ヘルスケア市場は、ワクチン、医薬品、医薬品飼料添加物、診断薬、ソフトウェア＆サービス、その他に区分されます。2023年には、様々な馬の健康状態に対する効果的な治療法の需要に牽引され、医薬品が最も高い収益を上げました。しかし、予測期間中（2024-2032年）に最もCAGRが高いのは、ソフトウェア＆サービス分野です。これは、馬ヘルスケア管理システムが普及し、馬の福祉全体に不可欠なものとなったためです。

適応症別市場セグメンテーション：筋骨格系疾患と寄生虫駆除が市場を独占

適応症別セグメンテーションには、筋骨格系障害、寄生虫駆除、内科、馬ヘルペスウイルス、馬脳脊髄炎、馬インフルエンザ、西ナイルウイルス、破傷風、その他が含まれます。2023年には、筋骨格系障害と寄生虫駆除が最も高い収益を記録したが、これは馬の健康への懸念が一般的であることを反映しています。しかし、予測期間中のCAGRが最も高いのは、馬ヘルペスウイルスと馬インフルエンザの分野であり、馬社会における健康の優先順位の移り変わりを示しています。

北米が世界のリーダーであり続ける

馬ヘルスケア市場は、地域によって収益貢献とCAGRが異なり、多様な地域動向を示しています。北米は、確立された馬術産業と馬ヘルスケアに関する高い認知度により、2023年に最も収益が高い地域に浮上しました。しかし、予測期間中にCAGRが最も高い地域はアジア太平洋と予想されます。これは、アジア太平洋地域における馬術スポーツやレクリエーションへの関心の高まりと、馬の健康への関心の高まりを反映しています。

市場競争は予測期間中に激化へ

馬ヘルスケア市場は、Zoetis Inc.、Boehringer Ingelheim、Merck &Co.、Ceva、Sound、Hallmarq Veterinary Imaging、Esaote SPA、Vetoquinol S.A.、IDEXX Laboratories, Inc.、Dechra Pharmaceuticals PLCなどの主要企業による激しい競争が特徴です。これらの企業は、製品革新、提携、買収などの戦略を採用し、市場での地位を強化しています。2023年、これらのプレイヤーの市場総収益は[実際の収益数値を記載]であり、2024年から2032年までの予測期間中に増加が予想されます。

目次

第1章 序文

• レポート内容
  • 報告書の目的
  • 対象者
  • 主な提供商品
• 市場セグメンテーション
• 調査手法
  • フェーズⅠ-二次調査
  • フェーズⅡ-一次調査
  • フェーズⅢ-有識者レビュー
  • 前提条件
  • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 馬ヘルスケア市場：競合分析

• 主要ベンダーの市場での位置付け
• ベンダーが採用する戦略
• 主要な産業戦略
• ティア分析：2023 vs 2032

第4章 馬ヘルスケア市場：マクロ分析と市場力学

• イントロダクション
• 世界の馬ヘルスケア市場金額 2022-2032
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 主な課題
  • 主な機会
• 促進要因と抑制要因の影響分析
• シーソー分析
• ポーターのファイブフォースモデル
  • サプライヤーパワー
  • バイヤーパワー
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係
• PESTEL分析
  • 政治的情勢
  • 経済情勢
  • テクノロジーの情勢
  • 法的情勢
  • 社会的情勢

第5章 馬ヘルスケア市場：製品別 2022-2032

• 市場概要
• 成長・収益分析：2023 vs 2032
• 数量と価格の分析2022-2032
• 市場セグメンテーション
  • ワクチン
  • 医薬品
    • 寄生虫駆除剤
    • 抗感染症薬
    • 抗炎症剤と鎮痛剤
    • その他の医薬品
  • 薬用飼料添加物
  • 診断
  • ソフトウェアとサービス
  • その他

第6章 馬ヘルスケア市場：適応症別 2022-2032

• 市場概要
• 成長・収益分析：2023 vs 2032
• 数量と価格の分析2022-2032
• 市場セグメンテーション
  • 筋骨格系疾患
  • 寄生虫駆除
  • 内科
  • 馬ヘルペスウイルス
  • 馬脳脊髄炎
  • 馬インフルエンザ
  • ウエストナイルウイルス
  • 破傷風
  • その他

第7章 馬ヘルスケア市場：アクティビティ別 2022-2032

• 市場概要
• 成長・収益分析：2023 vs 2032
• 数量と価格の分析2022-2032
• 市場セグメンテーション
  • スポーツ/レース
  • レクリエーション
  • その他

第8章 馬ヘルスケア市場：流通チャネル別 2022-2032

• 市場概要
• 成長・収益分析：2023 vs 2032
• 数量と価格の分析2022-2032
• 市場セグメンテーション
  • 動物病院とクリニック
  • eコマース
  • その他

第9章 北米の馬ヘルスケア市場 2022-2032

• 市場概要
• 馬ヘルスケア市場：製品別 2022-2032
• 馬ヘルスケア市場：適応症別 2022-2032
• 馬ヘルスケア市場：アクティビティ別 2022-2032
• 馬ヘルスケア市場：流通チャネル別 2022-2032
• 馬ヘルスケア市場：地域別 2022-2032
  • 北米
    • 米国
    • カナダ
    • その他北米地域

第10章 英国と欧州連合の馬ヘルスケア市場 2022-2032

• 市場概要
• 馬ヘルスケア市場：製品別 2022-2032
• 馬ヘルスケア市場：適応症別 2022-2032
• 馬ヘルスケア市場：アクティビティ別 2022-2032
• 馬ヘルスケア市場：流通チャネル別 2022-2032
• 馬ヘルスケア市場：地域別 2022-2032
  • 英国と欧州連合
    • 英国
    • ドイツ
    • スペイン
    • イタリア
    • フランス
    • その他欧州地域

第11章 アジア太平洋の馬ヘルスケア市場 2022-2032

• 市場概要
• 馬ヘルスケア市場：製品別 2022-2032
• 馬ヘルスケア市場：適応症別 2022-2032
• 馬ヘルスケア市場：アクティビティ別 2022-2032
• 馬ヘルスケア市場：流通チャネル別 2022-2032
• 馬ヘルスケア市場：地域別 2022-2032
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域

第12章 ラテンアメリカの馬ヘルスケア市場 2022-2032

• 市場概要
• 馬ヘルスケア市場：製品別 2022-2032
• 馬ヘルスケア市場：適応症別 2022-2032
• 馬ヘルスケア市場：アクティビティ別 2022-2032
• 馬ヘルスケア市場：流通チャネル別 2022-2032
• 馬ヘルスケア市場：地域別 2022-2032
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域

第13章 中東・アフリカの馬ヘルスケア市場 2022-2032

• 市場概要
• 馬ヘルスケア市場：製品別 2022-2032
• 馬ヘルスケア市場：適応症別 2022-2032
• 馬ヘルスケア市場：アクティビティ別 2022-2032
• 馬ヘルスケア市場：流通チャネル別 2022-2032
• 馬ヘルスケア市場：地域別 2022-2032
  • 中東・アフリカ
    • GCC
    • アフリカ
    • その他中東・アフリカ地域

第14章 企業プロファイル

• Zoetis Inc.
• Boehringer Ingelheim
• Merck & Co.
• Ceva
• Sound
• Hallmarq Veterinary Imaging
• Esaote SPA
• Vetoquinol S.A.
• IDEXX Laboratories Inc.
• Dechra Pharmaceuticals PLC
• その他の主要企業

List of Tables

• TABLE 1 Global Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 2 Global Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 3 Global Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 4 Global Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 5 Global Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 6 North America Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 7 North America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 8 North America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 9 North America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 10 North America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 11 U.S. Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 12 U.S. Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 13 U.S. Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 14 U.S. Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 15 U.S. Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 16 Canada Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 17 Canada Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 18 Canada Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 19 Canada Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 20 Canada Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 21 Rest of North America Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 22 Rest of North America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 23 Rest of North America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 24 Rest of North America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 25 Rest of North America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 26 UK and European Union Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 27 UK and European Union Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 28 UK and European Union Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 29 UK and European Union Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 30 UK and European Union Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 31 UK Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 32 UK Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 33 UK Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 34 UK Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 35 UK Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 36 Germany Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 37 Germany Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 38 Germany Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 39 Germany Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 40 Germany Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 41 Spain Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 42 Spain Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 43 Spain Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 44 Spain Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 45 Spain Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 46 Italy Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 47 Italy Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 48 Italy Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 49 Italy Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 50 Italy Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 51 France Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 52 France Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 53 France Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 54 France Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 55 France Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 56 Rest of Europe Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 57 Rest of Europe Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 58 Rest of Europe Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 59 Rest of Europe Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 60 Rest of Europe Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 61 Asia Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 62 Asia Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 63 Asia Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 64 Asia Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 65 Asia Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 66 China Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 67 China Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 68 China Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 69 China Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 70 China Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 71 Japan Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 72 Japan Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 73 Japan Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 74 Japan Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 75 Japan Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 76 India Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 77 India Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 78 India Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 79 India Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 80 India Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 81 Australia Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 82 Australia Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 83 Australia Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 84 Australia Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 85 Australia Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 86 South Korea Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 87 South Korea Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 88 South Korea Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 89 South Korea Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 90 South Korea Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 91 Latin America Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 92 Latin America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 93 Latin America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 94 Latin America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 95 Latin America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 96 Brazil Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 97 Brazil Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 98 Brazil Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 99 Brazil Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 100 Brazil Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 101 Mexico Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 102 Mexico Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 103 Mexico Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 104 Mexico Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 105 Mexico Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 106 Rest of Latin America Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 107 Rest of Latin America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 108 Rest of Latin America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 109 Rest of Latin America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 110 Rest of Latin America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 111 Middle East and Africa Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 112 Middle East and Africa Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 113 Middle East and Africa Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 114 Middle East and Africa Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 115 Middle East and Africa Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 116 GCC Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 117 GCC Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 118 GCC Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 119 GCC Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 120 GCC Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 121 Africa Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 122 Africa Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 123 Africa Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 124 Africa Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 125 Africa Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
• TABLE 126 Rest of Middle East and Africa Equine Healthcare Market By Product, 2022-2032, USD (Million)
• TABLE 127 Rest of Middle East and Africa Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 128 Rest of Middle East and Africa Equine Healthcare Market By Indication, 2022-2032, USD (Million)

• TABLE 129 Rest of Middle East and Africa Equine Healthcare Market By Activity, 2022-2032, USD (Million)
• TABLE 130 Rest of Middle East and Africa Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)

List of Figures

• FIG. 1 Global Equine Healthcare Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Equine Healthcare Market: Quality Assurance
• FIG. 5 Global Equine Healthcare Market, By Product, 2023
• FIG. 6 Global Equine Healthcare Market, By Indication, 2023
• FIG. 7 Global Equine Healthcare Market, By Activity, 2023
• FIG. 8 Global Equine Healthcare Market, By Distribution Channel, 2023
• FIG. 9 Global Equine Healthcare Market, By Geography, 2023
• FIG. 10 Market Geographical Opportunity Matrix - Global Equine Healthcare Market, 2023

FIG. 11Market Positioning of Key Equine Healthcare Market Players, 2023

FIG. 12Global Equine Healthcare Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

• FIG. 13 Global Equine Healthcare Market, By Product, 2023 Vs 2032, %
• FIG. 14 Global Equine Healthcare Market, By Indication, 2023 Vs 2032, %
• FIG. 15 Global Equine Healthcare Market, By Activity, 2023 Vs 2032, %
• FIG. 16 Global Equine Healthcare Market, By Distribution Channel, 2023 Vs 2032, %
• FIG. 17 U.S. Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 18 Canada Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 19 Rest of North America Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 20 UK Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 21 Germany Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 22 Spain Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 23 Italy Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 24 France Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 25 Rest of Europe Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 26 China Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 27 Japan Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 28 India Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 29 Australia Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 30 South Korea Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 31 Rest of Asia Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 32 Brazil Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 33 Mexico Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 34 Rest of Latin America Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 35 GCC Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 36 Africa Equine Healthcare Market (US$ Million), 2022 - 2032
• FIG. 37 Rest of Middle East and Africa Equine Healthcare Market (US$ Million), 2022 - 2032

The equine healthcare market is expected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2032, driven by key drivers such as preventive healthcare measures, advancements in diagnostics and treatment, and the rising focus on equine sports and recreation. However, challenges related to cost and accessibility pose constraints. Market segmentation underscores the dominance of specific product categories and indications, while geographic trends highlight regional variations in market dynamics. The competitive landscape emphasizes the strategic efforts of key players to navigate this dynamic market and capitalize on emerging opportunities. As the industry evolves, addressing accessibility issues and fostering innovation will be crucial for sustained success in the equine healthcare market.

Increasing Emphasis on Preventive Healthcare

The equine healthcare market is experiencing a notable boost due to the rising emphasis on preventive healthcare measures for horses. Horse owners and caretakers are increasingly recognizing the importance of vaccines and medicinal feed additives to prevent diseases and maintain the overall health of equines. This trend is evidenced by a substantial increase in the adoption of preventive healthcare practices in the equine community.

Advancements in Diagnostics and Treatment

Advancements in equine diagnostics and pharmaceuticals have significantly contributed to the market's growth. The development of sophisticated diagnostic tools and effective pharmaceuticals for musculoskeletal disorders, internal medicine, and viral infections like Equine Herpes Virus and Equine Influenza has enhanced the ability to diagnose and treat various health conditions in horses. This trend is substantiated by the increasing use of advanced diagnostics and pharmaceuticals in equine veterinary practices.

Rising Focus on Equine Sports and Recreation

The growing popularity of equine sports and recreational activities is driving the demand for healthcare products and services tailored to the unique needs of performance horses. This includes specialized treatments for musculoskeletal disorders and parasite control, as well as the adoption of software and services for comprehensive healthcare management. The increasing engagement of horses in various competitive and leisure activities is a key driver influencing market dynamics.

Market Restraint

Despite the positive trends, the equine healthcare market faces a notable restraint related to cost and accessibility. The high cost of advanced diagnostics, pharmaceuticals, and specialized healthcare services poses a challenge for horse owners, especially in regions where accessibility to equine healthcare resources is limited. This constraint hinders the widespread adoption of advanced healthcare solutions in certain segments of the equine community.

Market Analysis by Product: Pharmaceuticals Dominate the Market

The equine healthcare market is segmented into vaccines, pharmaceuticals, medicinal feed additives, diagnostics, software & services, and others. In 2023, the highest revenue was generated by pharmaceuticals, driven by the demand for effective treatments for various equine health conditions. However, the highest CAGR during the forecast period (2024-2032) is expected in the software & services segment, as equine healthcare management systems gain traction and become integral to overall equine welfare.

Market Segmentation by Indication: Musculoskeletal Disorders and Parasite Control Dominate the Market

The indication-based segmentation includes musculoskeletal disorders, parasite control, internal medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, and others. In 2023, musculoskeletal disorders and parasite control recorded the highest revenue, reflecting the prevalent health concerns among horses. However, the highest CAGR during the forecast period is expected in the Equine Herpes Virus and Equine Influenza segments, indicating a shifting landscape of health priorities in the equine community.

North America Remains the Global Leader

The equine healthcare market exhibits diverse geographic trends, with varying revenue contributions and CAGR across regions. North America emerged as the region with the highest revenue in 2023, driven by a well-established equine industry and a high level of awareness regarding equine healthcare. However, the region with the highest CAGR during the forecast period is anticipated to be Asia-Pacific, reflecting a growing interest in equine sports and recreation and an increasing focus on equine health in this region.

Market Competition to Intensify during the Forecast Period

The equine healthcare market features intense competition among key players, including Zoetis Inc., Boehringer Ingelheim, Merck & Co., Ceva, Sound, Hallmarq Veterinary Imaging, Esaote SPA, Vetoquinol S.A., IDEXX Laboratories, Inc., Dechra Pharmaceuticals PLC, and others. These companies employ strategies such as product innovation, collaborations, and acquisitions to strengthen their market position. In 2023, the total market revenues for these players were [provide actual revenue figures], with an expected increase during the forecast period from 2024 to 2032.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofEquine Healthcare market are as follows:

• Research and development budgets of manufacturers and government spending

• Revenues of key companies in the market segment

• Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Equine Healthcare market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

• Vaccines

• Pharmaceuticals

• Parasiticides

• Anti-infectives

• Anti-inflammatory & Analgesics

• Other Pharmaceuticals

• Medicinal Feed Additives

• Diagnostics

• Software & Services

• Others

Indication

• Musculoskeletal Disorders

• Parasite Control

• Internal Medicine

• Equine Herpes Virus

• Equine Encephalomyelitis

• Equine Influenza

• West Nile Virus

• Tetanus

• Others

Activity

• Sports/Racing

• Recreation

• Others

Distribution Channel

• Veterinary Hospitals & Clinics

• E-commerce

• Others

Region Segment (2021-2031; US$ Million)

• North America
  • U.S.
  • Canada
  • Rest of North America

• UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe

• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America

• Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report:

• What are the key micro and macro environmental factors that are impacting the growth of Equine Healthcare market?

• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

• Estimated forecast and market projections up to 2031.

• Which segment accounts for the fastest CAGR during the forecast period?

• Which market segment holds a larger market share and why?

• Are low and middle-income economies investing in the Equine Healthcare market?

• Which is the largest regional market for Equine Healthcare market?

• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

• Which are the key trends driving Equine Healthcare market growth?

• Who are the key competitors and what are their key strategies to enhance their market presence in the Equine Healthcare market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Equine Healthcare Market
• 2.2. Global Equine Healthcare Market, By Product, 2023 (US$ Million)
• 2.3. Global Equine Healthcare Market, By Indication, 2023 (US$ Million)
• 2.4. Global Equine Healthcare Market, By Activity, 2023 (US$ Million)
• 2.5. Global Equine Healthcare Market, By Distribution Channel, 2023 (US$ Million)
• 2.6. Global Equine Healthcare Market, By Geography, 2023 (US$ Million)
• 2.7. Attractive Investment Proposition by Geography, 2023

3. Equine Healthcare Market: Competitive Analysis

• 3.1. Market Positioning of Key Equine Healthcare Market Vendors
• 3.2. Strategies Adopted by Equine Healthcare Market Vendors
• 3.3. Key Industry Strategies
• 3.4. Tier Analysis 2023 Versus 2032

4. Equine Healthcare Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Equine Healthcare Market Value, 2022 - 2032, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis
• 4.6. Porter's Five Force Model
  • 4.6.1. Supplier Power
  • 4.6.2. Buyer Power
  • 4.6.3. Threat Of Substitutes
  • 4.6.4. Threat Of New Entrants
  • 4.6.5. Competitive Rivalry
• 4.7. PESTEL Analysis
  • 4.7.1. Political Landscape
  • 4.7.2. Economic Landscape
  • 4.7.3. Technology Landscape
  • 4.7.4. Legal Landscape
  • 4.7.5. Social Landscape

5. Equine Healthcare Market: By Product, 2022-2032, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2023 Versus 2032
• 5.3. Volume and Pricing Analysis, 2022-2032
• 5.4. Market Segmentation
  • 5.4.1. Vaccines
  • 5.4.2. Pharmaceuticals
    • 5.4.2.1. Parasiticides
    • 5.4.2.2. Anti-infectives
    • 5.4.2.3. Anti-inflammatory & Analgesics
    • 5.4.2.4. Other Pharmaceuticals
  • 5.4.3. Medicinal Feed Additives
  • 5.4.4. Diagnostics
  • 5.4.5. Software & Services
  • 5.4.6. Others

6. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2023 Versus 2032
• 6.3. Volume and Pricing Analysis, 2022-2032
• 6.4. Market Segmentation
  • 6.4.1. Musculoskeletal Disorders
  • 6.4.2. Parasite Control
  • 6.4.3. Internal Medicine
  • 6.4.4. Equine Herpes Virus
  • 6.4.5. Equine Encephalomyelitis
  • 6.4.6. Equine Influenza
  • 6.4.7. West Nile Virus
  • 6.4.8. Tetanus
  • 6.4.9. Others

7. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)

• 7.1. Market Overview
• 7.2. Growth & Revenue Analysis: 2023 Versus 2032
• 7.3. Volume and Pricing Analysis, 2022-2032
• 7.4. Market Segmentation
  • 7.4.1. Sports/Racing
  • 7.4.2. Recreation
  • 7.4.3. Others

8. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

• 8.1. Market Overview
• 8.2. Growth & Revenue Analysis: 2023 Versus 2032
• 8.3. Volume and Pricing Analysis, 2022-2032
• 8.4. Market Segmentation
  • 8.4.1. Veterinary Hospitals & Clinics
  • 8.4.2. E-commerce
  • 8.4.3. Others

9. North America Equine Healthcare Market, 2022-2032, USD (Million)

• 9.1. Market Overview
• 9.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
• 9.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
• 9.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
• 9.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
• 9.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
  • 9.6.1.North America
    • 9.6.1.1. U.S.
      • 9.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 9.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 9.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 9.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 9.6.1.2. Canada
      • 9.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 9.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 9.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 9.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 9.6.1.3. Rest of North America
      • 9.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 9.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 9.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 9.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

10. UK and European Union Equine Healthcare Market, 2022-2032, USD (Million)

• 10.1. Market Overview
• 10.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
• 10.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
• 10.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
• 10.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
• 10.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
  • 10.6.1.UK and European Union
    • 10.6.1.1. UK
      • 10.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 10.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 10.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 10.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 10.6.1.2. Germany
      • 10.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 10.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 10.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 10.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 10.6.1.3. Spain
      • 10.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 10.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 10.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 10.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 10.6.1.4. Italy
      • 10.6.1.4.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 10.6.1.4.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 10.6.1.4.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 10.6.1.4.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 10.6.1.5. France
      • 10.6.1.5.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 10.6.1.5.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 10.6.1.5.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 10.6.1.5.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 10.6.1.6. Rest of Europe
      • 10.6.1.6.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 10.6.1.6.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 10.6.1.6.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 10.6.1.6.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

11. Asia Pacific Equine Healthcare Market, 2022-2032, USD (Million)

• 11.1. Market Overview
• 11.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
• 11.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
• 11.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
• 11.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
• 11.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
  • 11.6.1.Asia Pacific
    • 11.6.1.1. China
      • 11.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 11.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 11.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 11.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 11.6.1.2. Japan
      • 11.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 11.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 11.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 11.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 11.6.1.3. India
      • 11.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 11.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 11.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 11.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 11.6.1.4. Australia
      • 11.6.1.4.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 11.6.1.4.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 11.6.1.4.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 11.6.1.4.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 11.6.1.5. South Korea
      • 11.6.1.5.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 11.6.1.5.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 11.6.1.5.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 11.6.1.5.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 11.6.1.6. Rest of Asia Pacific
      • 11.6.1.6.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 11.6.1.6.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 11.6.1.6.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 11.6.1.6.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

12. Latin America Equine Healthcare Market, 2022-2032, USD (Million)

• 12.1. Market Overview
• 12.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
• 12.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
• 12.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
• 12.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
• 12.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
  • 12.6.1.Latin America
    • 12.6.1.1. Brazil
      • 12.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 12.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 12.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 12.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 12.6.1.2. Mexico
      • 12.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 12.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 12.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 12.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 12.6.1.3. Rest of Latin America
      • 12.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 12.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 12.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 12.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

13. Middle East and Africa Equine Healthcare Market, 2022-2032, USD (Million)

• 13.1. Market Overview
• 13.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
• 13.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
• 13.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
• 13.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
• 13.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
  • 13.6.1.Middle East and Africa
    • 13.6.1.1. GCC
      • 13.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 13.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 13.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 13.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 13.6.1.2. Africa
      • 13.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 13.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 13.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 13.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
    • 13.6.1.3. Rest of Middle East and Africa
      • 13.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
      • 13.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
      • 13.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
      • 13.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

14. Company Profile

• 14.1. Zoetis Inc.
  • 14.1.1. Company Overview
  • 14.1.2. Financial Performance
  • 14.1.3. Product Portfolio
  • 14.1.4. Strategic Initiatives
• 14.2. Boehringer Ingelheim
  • 14.2.1. Company Overview
  • 14.2.2. Financial Performance
  • 14.2.3. Product Portfolio
  • 14.2.4. Strategic Initiatives
• 14.3. Merck & Co.
  • 14.3.1. Company Overview
  • 14.3.2. Financial Performance
  • 14.3.3. Product Portfolio
  • 14.3.4. Strategic Initiatives
• 14.4. Ceva
  • 14.4.1. Company Overview
  • 14.4.2. Financial Performance
  • 14.4.3. Product Portfolio
  • 14.4.4. Strategic Initiatives
• 14.5. Sound
  • 14.5.1. Company Overview
  • 14.5.2. Financial Performance
  • 14.5.3. Product Portfolio
  • 14.5.4. Strategic Initiatives
• 14.6. Hallmarq Veterinary Imaging
  • 14.6.1. Company Overview
  • 14.6.2. Financial Performance
  • 14.6.3. Product Portfolio
  • 14.6.4. Strategic Initiatives
• 14.7. Esaote SPA
  • 14.7.1. Company Overview
  • 14.7.2. Financial Performance
  • 14.7.3. Product Portfolio
  • 14.7.4. Strategic Initiatives
• 14.8. Vetoquinol S.A.
  • 14.8.1. Company Overview
  • 14.8.2. Financial Performance
  • 14.8.3. Product Portfolio
  • 14.8.4. Strategic Initiatives
• 14.9. IDEXX Laboratories, Inc.
  • 14.9.1. Company Overview
  • 14.9.2. Financial Performance
  • 14.9.3. Product Portfolio
  • 14.9.4. Strategic Initiatives
• 14.10. Dechra Pharmaceuticals PLC
  • 14.10.1. Company Overview
  • 14.10.2. Financial Performance
  • 14.10.3. Product Portfolio
  • 14.10.4. Strategic Initiatives
• 14.11. Other Notable Players
  • 14.11.1. Company Overview
  • 14.11.2. Financial Performance
  • 14.11.3. Product Portfolio
  • 14.11.4. Strategic Initiatives